Skip Navigation
Search Menu
Wilmer Eye Institute

In This Section      
Print This Page

Retina Division

The Retina Division treats retina-related disorders and conditions, such as macular degeneration, diabetic retinopathy, retinal detachment, vein occlusion and macular edema.

appointment icon

Request an Appointment: 410-955-3518

diabetic retinopathyConditions We Treat
Our experts treat and manage simple and advanced conditions involving the retina.
division chief Dr. Neil BresslerOur Experts
Meet the renowned team of retina experts who will help find the treatment that is best for you.
Dr. Peter Gehlbach in the lab with a studentOur Research
Explore the groundbreaking research and discoveries that are transforming the study and treatment of retinal diseases.

The Wilmer Eye Institute Difference

Innovative Treatments | Bionic Eye

After a life of deafness and nearly a decade of complete blindness due to Usher syndrome and retinitis pigmentosa, Adolf Levi, 83, underwent the first bionic eye implant at Wilmer to restore his vision. Hear James Handa, M.D., discuss this extraordinary case.

Dr. Gehlbach in the engineering lab

Our Collaboration | Engineering Better Tools

With generous support for Wilmer's faculty, Peter Gehlbach, M.D., Ph.D., collaborates with the Johns Hopkins' Whiting School of Engineering to develop tools that help microsurgeons to improve precision, efficiency and safety. Learn more.

Upcoming Events

Wilmer Eye Institute CME Event: Retina Festival 2017 on Friday, May 5, 2017

Dr. Handa in surgery

Retina FESTIVAL 2017 is an “all-star” line-up of more than 50 faculty members from around the world.This Johns Hopkins Wilmer Eye Institute CME event precedes one of the largest vision research meetings in the world, the Annual Meeting of the Association for Research in Vision in Ophthalmology (ARVO), being held in Baltimore for the first time.  Learn more.

Retina Faculty in the News

Wilmer Study On Americans' Fear of Blindness is Featured in the New York Times

Drs. Adrienne Scott and Neil Bressler published the study, "Public Attitudes About Eye and Vision Health" late last year. Featured in the New York Times, this is the first study to gauge the importance and awareness of eye health across ethnic and racial groups in the US. Learn more.

New Peptide Could Improve Treatment for Vision-Threatening Disease

Johns Hopkins researchers, including Peter Campochiaro, M.D., and Jordan Green, Ph.D., report that a new peptide holds promise for improving treatment for degenerative retinal diseases, such as age-related macular degeneration, diabetic macular edema and diabetic retinopathy. Learn more.

Dr. Arevalo Appointed Honorary Member of Spanish Macula Club

Fernando Arevalo, M.D. was appointed an Honorary Member of the Spanish Macula Club at the American Academy of Ophthalmology Meeting held this month in Chicago. Read more.

Dr. Maneep Singh Awarded Prestigious Clinician Scientist Career Development Award

Dr. Mandeep Singh, M.B.B.S., M.D., Ph.D, was awarded the prestigious Clinician Scientist Career Development Award from the Johns Hopkins School of Medicine. Read more.

Dr. Gehlbach Project Selected by Hopkins-Coulter Translational Partnership

A project co-led by Peter Gehlbach, M.D., entitled the “Optical Coherence Tomography Image and Sensor Guided Microsurgical Tools with Enhanced Surgical Functions​,” was selected for full funding by the Johns Hopkins-Coulter Translational Partnership Oversight Committee. Read more.

View more news and events from the Wilmer Eye Institute